The following table sets forth the components of changes
in our derivative financial instruments liability balance for the three months ended March 31, 2025.
Schedule of Derivative Liabilities at Fair Value
Date | |
Number of Warrants Outstanding | | |
Derivative Instrument Liability | |
Balance of derivative liability at December 31, 2024 | |
| 49,020 | | |
| 333,189 | |
Issuance of 2025 Series A warrants | |
| 3,443,461 | | |
| 1,348,441 | |
Issuance of 2025 Series B warrants | |
| 10,221,402 | | |
| 5,360,673 | |
Exercise of 2025 Series B warrants | |
| (8,834,034 | ) | |
| (9,757,913 | ) |
Change in fair value of warrants1 | |
| — | | |
| 4,202,178 | |
Balance of derivative liability at March 31, 2025 | |
| 4,879,849 | | |
| 1,486,568 | |
1 | The total change in fair value of warrants excludes the expense of $0.6 million of issuance cost. |
|